Wanqing Chen
4 Papers
Wanqing Chen is an academic researcher. The author has contributed to research in topics: Prospective cohort study & Medicine. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
One-off low-dose CT for lung cancer screening in China: a multicentre, population-based, prospective cohort study.
Ni Li,Fengwei Tan,Wanqing Chen,Min Dai,Fei Wang,Sipeng Shen,Wei Tang,Jing Li,Yiwen Yu,Wei Cao,Yongjie Xu,Chao Qin,Liang Zhao,Meng Zhu,Lanwei Guo,Zheng Wu,Zhuoyu Yang,Yadi Zheng,Hongda Chen,Yunyong Liu,Donghua Wei,Dong Dong,Ji Cao,Shaokai Zhang,Shipeng Yan,Ning Wang,Lingbin Du,Hongbing Shen,Ning Wu,Jie He,Sumei Cao,Ying Cheng,Hong Cui,Hua-Wei Dong,Xuesi Dong,Lianying Ge,Jiyong Gong,Mei He,Yutong He,Yimin Huang,Yao Huang,Yubei Huang,Yunchao Huang,Jing Jiang,Shengyan Jin,Yunxin Kong,Fang Li,Jibin Li,Xin Li,Xian-Zhen Liao,Yuqin Liu,Z. Luo,Zhang Lv,Hongxia Ma,Yanling Ma,Liang Qiao,Jiansong Ren,Jufang Shi,Bo Song,Bing-Bing Song,Shuming Song,Kai Su,Gang Sun,Lei Wang,Luopei Wei,Qing M. Wei,Yi Wen,Yunfeng Xi,Lei Yang,Zhihua Yin,Lianzheng Yu,Xinyang Yu,Min Zhang,Yong-Zhen Zhang,Baosen Zhou,Jinying Zhou,Chen Zhu,Kaiyong Zou +77 more
TL;DR: Wang et al. as discussed by the authors evaluated the effectiveness of one-off low-dose CT (LDCT) screening in the early detection of lung cancer in China, and showed that the LDCT screening was associated with significantly lower lung cancer mortality and all-cause mortality in a large population in China.
132
Preclinical development of a novel CD47 nanobody with less toxicity and enhanced anti-cancer therapeutic potential
Linlin Ma,Min Zhu,Junwei Gai,Guanghui Li,Qing Chang,Peng Qiao,Longlong Cao,Wanqing Chen,Siyuan Zhang,Yakun Wan +9 more
TL;DR: Both of HuNb1-IgG4 and anti-CD47/CD20 BsAb are potent antagonists of CD47/SIRPα pathway and promising candidates for clinical trials.
83
Uptake of lung cancer screening with low-dose computed tomography in China: A multi-centre population-based study
Wei Cao,Fengwei Tan,Kuangyu Liu,Zheng Wu,Fei Wang,Yiwen Yu,Yi Wen,Chao Qin,Yongjie Xu,Liang Zhao,Wei Tang,Jing Li,Xuesi Dong,Yadi Zheng,Zhuoyu Yang,Kai Su,Fang Li,Jufang Shi,Jiansong Ren,Yunyong Liu,Lianzheng Yu,Donghua Wei,Dong-Xia Dong,Ji Cao,Shaokai Zhang,Shipeng Yan,Ning Wang,Lingbin Du,Wanqing Chen,Ni Li,Jie He +30 more
TL;DR: Wang et al. as discussed by the authors used a logistic regression model to identify individual characteristics associated with the uptake of low-dose computed tomography (LDCT) scans, defined as whether the high-risk individual undertook LDCT scans in designated hospitals within six months following the initial risk assessment.
16